ICPI Week 2025 Wrap-Up
Dear Reader,
This year’s ICPI Week 2025 at KINTEX, South Korea, marked an extraordinary milestone for Asia’s pharmaceutical and biotech landscape. With 41,720 visitors and over $1.265 billion in export consultations, the event has not only broken records but also reinforced Korea’s leadership in next-gen manufacturing, sustainability, and international collaboration.
It was a privilege to share BioSpectrum Asia’s vision and editorial focus with AVING News. From regulatory trends to innovation showcases, our lens remains sharply focused on what's shaping the future of Asia’s life sciences. Read more
A standout theme this year: Korea’s commitment to low-carbon pharmaceutical manufacturing. Local companies demonstrated serious momentum toward eco-conscious processes — a sign that green biotech is not a trend but a mandate. Read more
This edition recorded the highest international turnout and commercial value to date. Partnerships were formed, contracts initiated, and cross-border trust reinforced across the exhibition halls. Read more
From digital bioprocessing to AI-assisted clinical solutions, these are the companies we believe will redefine pharma's future. Don’t miss our spotlight on innovation leaders of 2025. Read more
The sheer scale and diversity of ICPI Week 2025 made it clear — Asia is no longer a follower, but a formidable leader in global healthcare innovation. Read more
